Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Phenomenex lanza columnas y trampas Micro LC de vanguardia de 0,15 mm ID
  • USA - Français
  • USA - Deutsch
  • USA - English
  • USA - English

Permitir a los científicos dentro del laboratorio crear un mundo mejor en el exterior. Fabricante líder de HPLC Columns, columnas GC, productos de preparación de muestras y accesorios para cromatografía.

News provided by

Phenomenex

Jun 02, 2025, 09:00 ET

Share this article

Share toX

Share this article

Share toX

-  Phenomenex lanza columnas y trampas Micro LC de vanguardia de 0,15 mm ID para aplicaciones de precisión de bajo flujo

Garantiza mayor durabilidad y versatilidad para el análisis de biomarcadores de alta sensibilidad

TORRANCE, California, 2 de junio de 2025 /PRNewswire/ -- Phenomenex Inc., una Danaher Company, líder mundial en la investigación y fabricación de tecnologías avanzadas para las ciencias de la separación, ha anunciado la expansión de su cartera de productos en ASMS con la introducción de las microcolumnas LC y microtrampas de 0,15 mm ID, diseñadas específicamente para aplicaciones de bajo flujo. Las nuevas microcolumnas con núcleo-capa están diseñadas para abordar los desafíos diarios de los científicos en proteómica, metabolómica y caracterización de oligonucleótidos, ofreciendo un rendimiento excepcional en aplicaciones de bajo flujo. Optimizadas para operar eficientemente a velocidades de flujo de 1-5 µL/min, estas nuevas columnas representan un avance significativo en comparación con las columnas de microflujo tradicionales. Las nuevas columnas de 0,15 mm ID están disponibles en las variantes Kinetex 2,6 µmXB-C18, EVO C18 y F5, y Luna Omega 1,7 µm PS-C18 (próximamente), ideales para diversas aplicaciones de fase reversa. 

El doctor Tasso Milliotis, científico principal de AstraZeneca ya ha experimentado las extraordinarias ventajas de estas nuevas columnas:

"La nueva columna capilar LC de 150 x 0,15 mm (Kinetex 2,6 µm XB-C18, 100 Å) ofrece una robustez excepcional y un alto rendimiento de separación en condiciones exigentes para el análisis de biomarcadores de alta sensibilidad. Sus conectores hembra en ambos extremos garantizan una compatibilidad perfecta, lo que facilita su integración en cualquier sistema LC-MS de bajo flujo. En resumen, esta columna capilar combina durabilidad, eficiencia y versatilidad, y se ha convertido en nuestra columna estándar para aplicaciones de alta sensibilidad". 

Para añadir mayor capacidad de separación a aplicaciones específicas, Phenomenex también lanzó nuevas micro y nano trampas, con accesorios integrados para una fácil instalación, lo que garantiza una compatibilidad perfecta con una amplia gama de proveedores de instrumentos. Disponemos de amplias opciones de selectividad de fase que se pueden combinar con microcolumnas LC, acortando la distancia entre las aplicaciones de nanoflujo y microflujo. Diseñadas para ofrecer el mejor rendimiento en separaciones de baja dispersión, estas columnas soportan presiones de hasta 15.000 psi, ofreciendo un bajo consumo de disolvente y una mayor sensibilidad para análisis más robustos y precisos.

Recursos adicionales

  • Más información sobre las Microcolumnas LC aquí.

Acerca de Phenomenex 
Phenomenex es un líder tecnológico global comprometido con el desarrollo de novedosas soluciones de química analítica que resuelven los desafíos de separación y purificación de investigadores en laboratorios académicos, farmacéuticos, biotecnológicos, ambientales, de investigación clínica, gubernamentales e industriales. Desde el descubrimiento de fármacos y el desarrollo farmacéutico hasta la seguridad alimentaria y el análisis ambiental, las soluciones de cromatografía de Phenomenex impulsan la ciencia y ayudan a los investigadores a mejorar la salud y el bienestar humanos. Phenomenex es una empresa operativa dentro del grupo de ciencias de la vida de Danaher Corporation.

Para más información, visite www.phenomenex.com y siga el blog de la compañía en www.scienceunfiltered.com

Conecte en: LinkedIn, Twitter, Facebook, Instagram y YouTube

Logo - https://mma.prnewswire.com/media/2157889/PhenomenexLogo_Logo.jpg

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Phenomenex introduit des micro-colonnes et micro-pièges de chromatographie liquide d'avant-garde, d'un diamètre intérieur de 0,15 mm, pour des applications de précision à faible débit.

Phenomenex introduit des micro-colonnes et micro-pièges de chromatographie liquide d'avant-garde, d'un diamètre intérieur de 0,15 mm, pour des applications de précision à faible débit.

Phenomenex Inc., a Danaher Company, un leader mondial dans la recherche et la fabrication de technologies avancées pour les sciences de la...

Phenomenex bringt hochmoderne 0,15 mm ID Mikro-LC-Säulen und Fallen für präzise Low-Flow-Anwendungen auf den Markt

Phenomenex bringt hochmoderne 0,15 mm ID Mikro-LC-Säulen und Fallen für präzise Low-Flow-Anwendungen auf den Markt

Phenomenex Inc., ein Danaher-Unternehmen und weltweit führend in der Erforschung und Herstellung fortschrittlicher Technologien für die...

More Releases From This Source

Explore

Computer & Electronics

Computer & Electronics

Health Care & Hospitals

Health Care & Hospitals

STEM (Science, Tech, Engineering, Math)

STEM (Science, Tech, Engineering, Math)

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.